TY - JOUR
T1 - La polypose associée à MUTYH
T2 - Synthèse des données disponibles en 2020 et actualisation des recommandations françaises établies en 2012 sous l'égide de l'Institut National du Cancer (INCa)
AU - Buisine, Marie Pierre
AU - Bonnet, Delphine
AU - Bonadona, Valérie
AU - Coulet, Florence
AU - Baert-Desurmont, Stéphanie
AU - Dhooge, Marion
AU - Saurin, Jean Christophe
AU - Remenieras, Audrey
AU - Bignon, Yves Jean
AU - Caron, Olivier
AU - de Pauw, Antoine
AU - Colas, Chrystelle
AU - Buecher, Bruno
N1 - Publisher Copyright:
© 2020 John Libbey Eurotext. All rights reserved.
PY - 2020/4/1
Y1 - 2020/4/1
N2 - MUTYH-associated polyposis (MUTYH-associated polyposis, MAP) is an autosomal recessive inheritance disorder related to bi-allelic constitutional pathogenic variants of the MUTYH gene which was first described in 2002. In 2011, a group of French experts composed of clinicians and biologists, performed a summary of the available data on this condition and drew up recommendations concerning the indications and the modalities of molecular analysis of the MUTYH gene in index cases and their relatives, as well as the management of affected individuals. In view of recent developments, some recommendations have become obsolete, in particular with regard to the molecular analysis strategy since MUTYH gene has been recently included in a consensus panel of 14 genes predisposing to colorectal cancer. This led us to revise all the points of the previous expertise. We report here the revised version of this work which successively considers the phenotype and the tumor risks associated with this genotype, the differential diagnoses, the indication criteria and the strategy of the molecular analysis and the recommendations for the management of affected individuals. We also discuss the phenotype and the tumor risks associated with mono-allelic pathogenic variants of MUTYH gene.
AB - MUTYH-associated polyposis (MUTYH-associated polyposis, MAP) is an autosomal recessive inheritance disorder related to bi-allelic constitutional pathogenic variants of the MUTYH gene which was first described in 2002. In 2011, a group of French experts composed of clinicians and biologists, performed a summary of the available data on this condition and drew up recommendations concerning the indications and the modalities of molecular analysis of the MUTYH gene in index cases and their relatives, as well as the management of affected individuals. In view of recent developments, some recommendations have become obsolete, in particular with regard to the molecular analysis strategy since MUTYH gene has been recently included in a consensus panel of 14 genes predisposing to colorectal cancer. This led us to revise all the points of the previous expertise. We report here the revised version of this work which successively considers the phenotype and the tumor risks associated with this genotype, the differential diagnoses, the indication criteria and the strategy of the molecular analysis and the recommendations for the management of affected individuals. We also discuss the phenotype and the tumor risks associated with mono-allelic pathogenic variants of MUTYH gene.
KW - Colorectal adenomatous polyposis
KW - Hereditary colorectal cancer
KW - MUTYH
KW - Multigene panel
UR - http://www.scopus.com/inward/record.url?scp=85086661758&partnerID=8YFLogxK
U2 - 10.1684/hpg.2020.1944
DO - 10.1684/hpg.2020.1944
M3 - Article 'review'
AN - SCOPUS:85086661758
SN - 2115-3310
VL - 27
SP - 396
EP - 406
JO - Hepato-Gastro et Oncologie Digestive
JF - Hepato-Gastro et Oncologie Digestive
IS - 4
ER -